Atom Grants
Discover

    Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)

    NCATS offers T32 grants to institutions for postdoctoral training in clinical & translational science, aiming to develop diverse researchers who can improve health outcomes.

    Overview
    Eligibility
    Sources (2)
    Similar Grants
    Researchers

    Funder: National Institutes of Health

    Due Dates: May 28, 2025 (New/Renewal/Resubmission) | September 29, 2025 (New/Renewal/Resubmission) | January 28, 2026 (New/Renewal/Resubmission) | May 28, 2026 (New/Renewal/Resubmission) | September 28, 2026 (New/Renewal/Resubmission) | January 28, 2027 (New/Renewal/Resubmission) | May 28, 2027 (New/Renewal/Resubmission) | September 28, 2027 (New/Renewal/Resubmission)

    Funding Amounts: Budgets are not limited but must reflect actual needs; up to 2–5 postdoctoral trainee slots per year (depending on CTSA hub tier); project period up to 5 years.

    Summary: Supports institutional postdoctoral training programs in clinical and translational science to develop a diverse workforce equipped to advance diagnostics, therapeutics, and health interventions.

    Key Information: Only CTSA UM1 hub institutions may apply; clinical trials led by trainees are not allowed, but research experience in mentor-led trials is permitted.


    Description

    This opportunity, offered by the National Center for Advancing Translational Sciences (NCATS) at NIH, provides Ruth L. Kirschstein National Research Service Award (NRSA) T32 grants to eligible Clinical and Translational Science Awards (CTSA) Program hubs. The goal is to support institutional postdoctoral research training programs that prepare scientists with doctoral degrees for impactful careers in clinical and translational science. Programs are expected to foster a diverse pool of trainees with the knowledge, skills, and abilities to advance diagnostics, therapeutics, clinical interventions, and behavioral modifications that improve health and address stakeholder needs.

    The program emphasizes:

    • High-quality, team-based, cross-disciplinary research training
    • Development of leadership, communication, and career skills
    • Exposure to the full translational science spectrum, including preclinical, clinical, implementation, and population health research
    • Evidence-informed mentoring and retention practices
    • Integration with the broader CTSA hub and its strengths

    Trainees may not lead independent clinical trials but can gain experience in mentor-led trials.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.